Effects of spinal cord stimulation on peripheral blood circulation in rats with streptozotocin-induced diabetes

Neuromodulation

Volumn 10, Issue 3, 2007, Pages 216-223

  Wu, Mingyuan ^a   Thorkilsen, MarieLouise Muus ^b   Qin, Chao ^a   Farber, Jay P ^a   Linderoth, Bengt ^c   Foreman, Robert D ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes; Spinal cord stimulation; Vasodilation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; PERIPHERAL CIRCULATION; RAT; SPINAL CORD STIMULATION; STREPTOZOCIN DIABETES; VASODILATATION;

EID: 34250846524     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2007.00111.x     Document Type: Article

References (24)

1. Osmundson PJ, Chesebro JH, O'Fallon WM, Zimmerman BR, Kazmier FJ, Palumbo PJ. A prospective study of peripheral occlusive arterial disease in diabetes. II. Vascular laboratory assessment. Mayo Clin Proc 1981 56 : 223 232.
2. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop. Circulation 1993 88 : 819 828.
3. Leibson CL, Ransom JE, Olson W, Zimmerman BR, O'Fallon WM, Palumbo PJ. Peripheral arterial disease, diabetes, and mortality. Diabetes Care 2004 27 : 2843 2849.
4. Linderoth B, Herregodts P, Meyerson BA. Sympathetic mediation of peripheral mediation of peripheral vasodilation induced by spinal cord stimulation: animal studies of the role of cholinergic and adrenergic receptor subtypes. Neurosurgery 1994 35 : 711 719.
5. Wu M, Komori N, Qin C, Farber JP, Linderoth B, Foreman RD. Sensory fibers containing vanilloid receptor-1 (VR-1) mediate spinal cord stimulation-induced vasodilation. Brain Res 2006 1107 : 177 184.
6. Linderoth B, Foreman RD. Mechanisms of spinal cord stimulation in painful syndromes: role of animal models. Pain Med 2006 7 : S14 S26.
7. Tanaka S, Komori N, Barron KW, Chandler MJ, Linderoth B, Foreman RD. Mechanisms of sustained cutaneous vasodilation induced by spinal cord stimulation. Auton Neurosci 2004 114 : 55 60.
8. Tanaka S, Barron KW, Chandler MJ, Linderoth B, Foreman RD. Role of primary afferents in spinal cord stimulation-induced vasodilation: characterization of fiber types. Brain Res 2003 10 : 191 198.
9. Erdek MA, Staats PS. Spinal cord stimulation for angina pectoris and peripheral vascular disease. Anesthesiol Clin North America 2003 21 : 797 804.
10. Petrakis IE, Sciacca V. Does autonomic neuropathy influence spinal cord stimulation therapy success in diabetic patients with critical lower limb ischemia? Surg Neurol 2000 53 : 182 189.
11. Meyerson BA, Linderoth B. Spinal cord stimulation. In : Loeser JD, ed. Bonica's management of pain, 3rd ed. Philadelphia, PA : Lippincott Williams & Wilkins, 2000 : 1857 1876.
12. Kanter M, Coskun O, Korkmaz A, Oter S. Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats. Anat Rec A Discov Mol Cell Evol Biol 2004 279 : 685 691.
13. Tanaka S, Barron KW, Chandler MJ, Linderoth B, Foreman RD. Local cooling alters neural mechanisms producing changes in peripheral blood flow by spinal cord stimulation. Auton Neurosci 2003 28 : 117 127.
14. Yorek MA, Coppey LJ, Gellett JS, Davidson EP. Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes. Exp Diabesity Res 2004 5 : 187 193.
15. Terata K, Coppey LJ, Davidson EP, Dunlap JA, Gutterman DD, Yorek MA. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. Br J Pharmacol 1999 128 : 837 843.
16. Davidson EP, Coppey LJ, Yorek MA. Activity and expression of the vanilloid receptor 1 (TRPV1) is altered by long-term diabetes in epineurial arterioles of the rat sciatic nerve. Diabetes Metab Res Rev 2006 22 : 211 219.
17. Wu M, Qin C, Foreman RD, Farber JP. Transient receptor potential vanilloid receptor-1 does not contribute to slowly adapting airway receptor activation by ammonia. Auton Neurosci 2007 133 : 121 127.
18. Wu M, Qin C, Farber JP, Linderoth B, Foreman RD. Role of peripheral terminals of vanilloid receptor-1 containing sensory fibers in spinal cord stimulation-induced vasodilation. The 36th Society of Neuroscience Meeting, Atlanta, GA, 2006, Poster # 4545/Z20.
19. Eguchi S, Tezuka S, Hobara N, Akiyama S, Kurosaki Y, Kawasaki H. Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries. Br J Pharmacol 2004 142 : 1137 1146.
20. Khan GM, Chen SR, Pan HL. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 2002 114 : 291 299.
21. Carnethon MR, Prineas RJ, Temprosa M et al. The association among autonomic nervous system function, incident diabetes, and intervention arm in the diabetes prevention program. Diabetes Care 2006 29 : 914 919.
22. Daulhac L, Mallet C, Courteix C et al. Diabetes-induced mechanical hyperalgesia involves spinal MAPKs activation in neurons and microglia via NMDA-dependent mechanisms. Mol Pharmacol 2006 70 : 1246 1254.
23. Wu M, Komori N, Qin C, Farber JP, Linderoth B, Foreman RD. Extracellular signal-regulated kinase (ERK) and protein kinase B (AKT) pathways involved in spinal cord stimulation (SCS)-induced vasodilation. 2006. FASEB J 20:A1402.
24. Barron KW, Croom JE, Ray CA, Chandler MJ, Foreman RD. Spinal integration of antidromic mediated cutaneous vasodilation during dorsal spinal cord stimulation in the rat. Neurosci Lett 1999 260 : 173 176.